BioLineRx Ltd. (BLRX) DCF Valuation

BioLineRx Ltd. (BLRX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

BioLineRx Ltd. (BLRX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Increase efficiency and improve precision with our (BLRX) DCF Calculator! Equipped with actual BioLineRx Ltd. data and customizable assumptions, this tool enables you to forecast, analyze, and value BioLineRx Ltd. like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 4.8 4.8 4.8 4.8 4.8 4.8
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -27.2 -22.0 -25.3 -28.5 -57.1 2.9 2.9 2.9 2.9 2.9
EBITDA, % 100 100 100 100 -1188.77 60 60 60 60 60
Depreciation .9 .9 .7 .7 1.4 4.1 4.1 4.1 4.1 4.1
Depreciation, % 100 100 100 100 28.83 85.77 85.77 85.77 85.77 85.77
EBIT -28.1 -22.9 -26.0 -29.2 -58.4 2.9 2.9 2.9 2.9 2.9
EBIT, % 100 100 100 100 -1217.6 60 60 60 60 60
Total Cash 27.5 22.6 57.1 51.1 43.0 4.8 4.8 4.8 4.8 4.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .6 .1 .1 .7 .7
Account Receivables, % 100 100 100 100 14.75
Inventories .0 .0 .0 -41.2 2.0 4.2 4.2 4.2 4.2 4.2
Inventories, % 100 100 100 100 40.69 88.14 88.14 88.14 88.14 88.14
Accounts Payable 7.8 5.9 5.6 7.0 10.9 4.8 4.8 4.8 4.8 4.8
Accounts Payable, % 100 100 100 100 226.44 100 100 100 100 100
Capital Expenditure -.1 .0 -.1 -.3 -.3 -.1 -.1 -.1 -.1 -.1
Capital Expenditure, % 100 100 100 100 -6.19 -1.24 -1.24 -1.24 -1.24 -1.24
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -29.6 -23.6 -27.1 -22.1 -58.4 2.7 2.7 2.7 2.7 2.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -21.6 -24.1 -26.8 20.3 -96.6 -4.8 6.8 6.8 6.8 6.8
WACC, % 13.12 13.12 13.12 11.08 13.12 12.71 12.71 12.71 12.71 12.71
PV UFCF
SUM PV UFCF 13.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 7
Terminal Value 65
Present Terminal Value 36
Enterprise Value 49
Net Debt 7
Equity Value 42
Diluted Shares Outstanding, MM 64
Equity Value Per Share 0.65

What You Will Receive

  • Comprehensive Financial Model: BioLineRx Ltd.’s actual data facilitates accurate DCF valuation.
  • Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automated updates allow you to view results immediately as you adjust parameters.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Adaptable and Reusable: Designed for versatility, enabling repeated application for in-depth forecasts.

Key Features

  • Comprehensive Data: BioLineRx Ltd.'s historical financial statements and pre-filled projections.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Monitor BioLineRx Ltd.'s intrinsic value recalculating instantly.
  • Intuitive Visualizations: Dashboard graphs illustrate valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  • 1. Access the Template: Download and open the Excel file containing BioLineRx Ltd.'s preloaded data.
  • 2. Modify Assumptions: Adjust critical inputs such as growth rates, WACC, and capital expenditures.
  • 3. View Results in Real-Time: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
  • 5. Utilize with Assurance: Present expert valuation insights to back your strategic decisions.

Why Choose This Calculator for BioLineRx Ltd. (BLRX)?

  • User-Friendly Interface: Perfect for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your financial analysis.
  • Real-Time Valuation: Observe immediate updates to BioLineRx’s valuation as you modify inputs.
  • Pre-Loaded Data: Comes with BioLineRx’s actual financial information for swift evaluations.
  • Preferred by Experts: Utilized by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling BioLineRx Ltd. (BLRX) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to BioLineRx Ltd. (BLRX).
  • Consultants: Deliver professional valuation insights regarding BioLineRx Ltd. (BLRX) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like BioLineRx Ltd. (BLRX) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to BioLineRx Ltd. (BLRX).

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations.
  • Real-World Data: BioLineRx Ltd.'s (BLRX) historical and projected financials preloaded for analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results.

No products were found matching.